Subsequent studies showed that EZH2 is upregulated in various solid malignancies including renal cell carcinoma [13], lung [14, 15], hepatocellular [16], gastric [17], and pancreatic cancer [18]. Here, EZH2 is linked to familial pancreatic carcinoma.